Opaxon Injection

About Opaxon 400 mcg/ml Injection

Opaxon 400 mcg/ml Injection is a medicine containing naloxone hydrochloride, made by Square Pharmaceuticals PLC. It is given by injection and belongs to a group of medicines used as an antidote to opioid medicines.

What is Opaxon 400 mcg/ml Injection?

Opaxon 400 mcg/ml Injection is an antidote preparation containing naloxone hydrochloride. It works by blocking the effects of opioid medicines at the body's opioid receptors. It is given by injection, and the doctor decides the dose and course for each patient. It is used in medical settings to reverse opioid depression, including breathing problems caused by opioids, and to help diagnose suspected opioid overdose. Because it reverses opioid effects, it is handled by trained healthcare staff who can watch the patient closely.

Uses of Opaxon

Opaxon Injection is used to reverse the effects of opioid medicines, including depression of breathing. This covers natural and synthetic opioids and certain mixed pain medicines. It is also used to help diagnose suspected opioid overdose. Only a doctor can decide whether it is suitable, and the doctor decides the dose and course. Ask the doctor or pharmacist if you are unsure why it has been prescribed.

How to use Opaxon

Opaxon Injection is given by a healthcare professional, usually into a vein, and sometimes into a muscle or under the skin if a vein route is not possible. You should not inject it yourself. The doctor decides the dose and how often it is given, adjusting it to the patient's response. Tell the medical team about all medicines the patient has taken.

Side effects of Opaxon

Side effects mostly relate to the reversal of opioid effects and can include restlessness, irritability, sleepiness, low mood, poor concentration, nausea and vomiting. Some patients may feel sudden withdrawal effects. Not everyone gets these effects. Tell the doctor or nurse straight away if any effect is severe or worrying, so it can be managed properly.

Safety and precautions

Tell the doctor if the patient is physically dependent on opioids or has received large doses of opioids, because sudden withdrawal effects may occur. Pregnancy and breastfeeding should be discussed with the doctor. The medicine is given only if the doctor judges the benefit justifies the risk. Ask the doctor first about any other medical conditions or medicines being taken.

Frequently asked questions

How should Opaxon Injection be stored?

Store it at 25°C and protect it from light. Keep it out of reach of children. If you are given a supply to keep, ask your pharmacist about safe storage and about what to do with any unused medicine.

What is Opaxon Injection used for, and what kind of medicine is it?

It is an antidote preparation containing naloxone hydrochloride. It is used to reverse the effects of opioid medicines, including breathing depression, and to help diagnose suspected opioid overdose. The doctor decides the dose and course.

What do the dosage form and strength mean?

The dosage form is an injection, so it is given by a healthcare professional rather than swallowed. The strength is 400 mcg/ml, meaning each millilitre of the liquid contains 400 micrograms of naloxone hydrochloride. The doctor decides the dose and course.

Who should be told before this medicine is given?

Tell the doctor if the patient is physically dependent on opioids, has received large doses of opioids, is pregnant or breastfeeding, or has other medical conditions. The doctor will decide whether it is suitable and will decide the dose and course.

Indications

Naloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and ... Read moreNaloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. Naloxone is also indicated for diagnosis of suspected or known acute opioid overdosage. Naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock

Pharmacology

Naloxone is a pure opioid antagonist that acts competitively at opioid receptors. While the mechanism of action of naloxone is not fully understood, the preponderance of evidence suggests that naloxone antagonizes the opioid effects by competing for the same receptor sites, especially the opioid mu receptor. Recently, naloxone has been shown to bind all three opioid receptors (mu, kappa and gamma) but the strongest binding is to the mu receptor.

Dosage & Administration

Reversal of central depression from opioid use during surgery:
  • Adult: 100-200 mcg at intervals of 2-3 minute, titrate dose according to response while maintaining analgesia.
  • Child: 5-10 mcg IV at 2-3 min intervals.
Opioid overdosage:
  • Adult: 0.4-2 mg repeated if necessary at 2-3 min intervals. If there is no response after a total of 10 mg has been given, consider the possibility of overdosage with other drugs. Reduce dose for opioid-dependent patients: 0.1-0.2 mg. IM/SC routes may be used (at IV doses) if IV admin is not feasible.
  • Child: Initially 10 mcg/kg IV followed by 100 mcg/kg IV if necessary. Alternatively, 0.4-0.8 mg IM or SC, repeated as necessary, if IV admin is not feasible.
Opioid-induced depression in neonates due to obstetric analgesia:
  • Child: 10 mcg/kg IV, IM or SC repeated at 2-3 min intervals if necessary or 60 mcg/kg as a single IM dose.

Interaction

Decreased effect of opioid analgesics.

Side Effects

Occur secondarily to reversal (withdrawal) of narcotic analgesia and sedation. Mental depression, apathy, inability to concentrate, sleepiness, irritability, anorexia, nausea, and vomiting in high oral doses during initial treatment of opiate addiction.

Pregnancy & Lactation

Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.

Precautions & Warnings

Patients physically dependent on opioids, or who have received large doses of opioids (acute withdrawal syndrome may be precipitated). Pregnancy and lactation.

Storage Conditions

Store at 25° C. Protect from light.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.